Management of Primary Malignant Renal Tumors

Monday, March 6, 2023

1:00 PM – 2:30 PM

Location:Phoenix Convention Center, 225AB

CE: 1.5 Credits

Coordinator(s)

Kamran Ahrar, MD,MBA,FSIR,FACR

Professor
MD Anderson Cancer Center

Disclosure(s): No financial relationships to disclose
Nishita Kothary, MD

Professor of Radiology
Stanford University School of Medicine

Disclosure(s): Boston Scientific Corp: Stock (Ongoing); Neptune medical: Management Position (Ongoing), Ownership Interest (Ongoing), Salaried Employee (Ongoing); Quantum surgical: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing); Varian Interventional Solutions: Consultant (Ongoing)

Disclosure(s):

Kamran Ahrar, MD,MBA,FSIR,FACR: No financial relationships to disclose

Nishita Kothary, MD: Boston Scientific Corp: Stock (Ongoing); Neptune medical: Management Position (Ongoing), Ownership Interest (Ongoing), Salaried Employee (Ongoing); Quantum surgical: Advisory Committee or Review Panel Member (Ongoing), Consultant (Ongoing); Varian Interventional Solutions: Consultant (Ongoing)

This categorical course provides a comprehensive review for management of renal cell carcinoma. Topics include presentation and staging of renal tumors, treatment recommendations by the American Urological Association, ablation techniques, complications and their management, follow up, and imaging algorithm.

Learning Objectives:

Outline treatment options for renal cell carcinoma
Describe ablation outcomes for renal cell carcinoma
Outline complications for ablation, strategies to avoid them, and management of complications

Presentations:

1:00 PM – 1:10 PM

Presentation, Staging, and AUA Recommendations for Renal Cell Carcinoma
Speaker: Nishita Kothary, MD – Stanford University School of Medicine
1:10 PM – 1:20 PM

Microwave Ablation is Fast and Effective for T1a Renal Tumors
Speaker: Timothy J. Ziemlewicz, MD – University of Wisconsin Hospital and Clinics
1:20 PM – 1:30 PM

Cryoablation is the best modality for ablation of T1a renal tumors
Speaker: Thomas Atwell, MD (he/him/his) – Mayo Clinic Rochester
1:30 PM – 1:40 PM

Radiofrequency ablation provides excellent results for ablation of T1a renal tumors
Speaker: Mohamed E. Abdelsalam, MD,M.Sc. (he/him/his) – UT MD Anderson Cancer Center
1:40 PM – 1:50 PM

Ablation of larger tumors: T1b and T2 renal tumors
Speaker: Andrew Gunn, MD – University of Alabama At Birmingham
1:50 PM – 2:00 PM

Potential complications, strategies to avoid them, and management
Speaker: Kamran Ahrar, MD,MBA,FSIR,FACR – MD Anderson Cancer Center
2:00 PM – 2:10 PM

Follow up and Imaging of Ablation Zone
Speaker: Ronald Arellano, MD – Department of Radiology, Massachusetts General Hospital
2:10 PM – 2:30 PM

Q & A